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Abstract How endoplasmic reticulum (ER) stress leads to cytotoxicity is ill-defined. Previously
we showed that HeLa cells readjust homeostasis upon proteostatically driven ER stress, triggered
by inducible bulk expression of secretory immunoglobulin M heavy chain (ms) thanks to the
unfolded protein response (UPR; Bakunts et al., 2017). Here we show that conditions that prevent
that an excess of the ER resident chaperone (and UPR target gene) BiP over ms is restored lead to
ms-driven proteotoxicity, i.e. abrogation of HRD1-mediated ER-associated degradation (ERAD), or
of the UPR, in particular the ATF6a branch. Such conditions are tolerated instead upon removal of
the BiP-sequestering first constant domain (CH1) from ms. Thus, our data define proteostatic ER
stress to be a specific consequence of inadequate BiP availability, which both the UPR and ERAD
redeem.
DOI: https://doi.org/10.7554/eLife.41168.001
Introduction
It is well-established that accumulation of unfolded proteins in the endoplasmic reticulum (ER)—a
condition referred to as ER stress—activates the unfolded protein response (UPR), which, in turn,
mitigates the stress, most notably through enhancing the ER chaperone content to boost the protein
folding capacity (Walter and Ron, 2011). What defines ER stress, and how ER stress may engender
cytotoxicity, however, are poorly understood issues. Moreover, it is still debated what feature of ER
stress activates the UPR. An important reason why these are still open questions is the wide-spread
use of ER stress-eliciting drugs, such as tunicamycin (Tm), which inhibits N-glycosylation, or thapsi-
gargin (Tg), which causes Ca2+ efflux from the ER (Walter and Ron, 2011). These drugs have pleio-
tropic effects and are inherently cytotoxic, hence obscuring important aspects of how ER
homeostasis can be restored by virtue of the UPR or not. To overcome the shortcomings of ER
stress-eliciting drugs, we recently have developed a HeLa cell-based model for proteostatically
driven ER stress (Bakunts et al., 2017). Inducible overexpression of the IgM subunits ms and the l
light chain, in stoichiometric amounts, leads to bulk secretion of IgM with little if any UPR activation.
In the absence of l, however, ms is retained in the ER, and maximally activates the three main UPR
branches, governed by IRE1a, PERK, and respectively, ATF6a. Yet, the cells successfully adapt to
the proteostatic insult by expanding the ER both in size and in chaperone content, such that cell via-
bility and growth are unaffected in the process, and UPR signaling subsides to a submaximal ampli-
tude once homeostasis is restored (Bakunts et al., 2017).
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The ER resident chaperone BiP stands out in the course of the adaptation to ms expression in two
ways. First, ER stress sensing and UPR signaling occur in a ms/BiP ratiometric fashion, that is the
amplitude of UPR signaling is maximal when ms levels eclipse those of BiP, which is sequestered
through binding to ms, while UPR signaling subsides to submaximal output when an excess of BiP
over ms is restored (Bakunts et al., 2017). ER homeostatic readjustment is due to the UPR, since BiP
is a key UPR target gene (Walter and Ron, 2011). Second, ER homeostatic readjustment to ms
expression causes a ~10-fold increase of BiP levels overall, which entails that BiP shifts from about
one tenth to about one third of the total protein mass in the ER, such that BiP is the only chaperone
in the ER of which the levels outmatch those of ms (Bakunts et al., 2017).
The two main models that have been proposed for UPR activation are that it entails i) dissociation
of BiP from the lumenal domains of the main ER stress sensors, IRE1a, PERK (Bertolotti et al.,
2000) and ATF6a (Shen et al., 2002), and ii) direct binding of unfolded proteins (Gardner and Wal-
ter, 2011; Karago¨z et al., 2017), including the Ig heavy chain CH1 domain (Karago¨z et al., 2017),
to these sensors. Based on insights obtained from ms-driven ER stress, we argue that these two UPR
activation models are not mutually exclusive. Rather, the two models are complementary and should
be unified, since in a three-way competition between UPR sensors, BiP, and an ER client protein (ms)
for binding one another, the ratio of UPR sensors bound to the client versus those bound to BiP
most robustly report on the client/BiP ratio, to which indeed the UPR signaling amplitude correlates
(Bakunts et al., 2017).
HeLa cells tolerate genetic ablation of the main three UPR transducers, but expression of ms in
the context of UPR-ablated cells causes synthetic lethality through apoptosis, underscoring the key
role the UPR has in restoring ER homeostasis (Bakunts et al., 2017). In this study we exploited this
synthetic lethality to define how ER stress becomes proteotoxic.
Results
IRE1a and PERK are expendable, but ATF6a is key for ms-provoked ER
homeostatic readjustment
To investigate in detail how the UPR sustains ER homeostatic readjustment to bulk ms expression, we
exploited cells in which IRE1a was deleted and PERK and ATF6a were silenced with good efficiency
(Bakunts et al., 2017), either individually or in combinations. Surprisingly, ablation of IRE1a and
PERK (either individually or in combination) had negligible effects on viability and growth of ms-
expressing cells, (Figure 1A,B), or on ATF6a activation (Figure 1C). Thus, IRE1a and PERK are dis-
pensable for restoring ER homeostasis upon bulk ms expression, and ER stress levels are not
enhanced in their absence (although there is some ATF6a activation already under basal conditions
when IRE1a and PERK are ablated; Figure 1C). Conversely, silencing of ATF6a alone caused
reduced growth and/or viability of ms-expressing cells (Figure 1A,B), implying that ER homeostasis
was not (fully) restored.
When ms is expressed for 3 days in wild-type cells, ER homeostasis is restored, and, consequently,
IRE1a and PERK signaling subsides to submaximal output (Bakunts et al., 2017). In ATF6a-silenced
cells, conversely, ER homeostasis is not restored, and, accordingly, signaling through the PERK and
IRE1a pathways remained persistently high (Figure 1C); that is levels of CHOP, a key downstream
effector of PERK (Harding et al., 2000), were increased, and IRE1a-mediated XBP1 mRNA splicing
(Calfon et al., 2002) was enhanced, as was evident from the increased prominence of the higher
mobility band, corresponding to the RT-PCR product of the XBP1S transcript from which the intron
has been removed (Calfon et al., 2002). Ablation of ATF6a in combination with ablation of IRE1a
and/or PERK caused apoptosis (Bakunts et al., 2017) and, consequently, abrogated viability of ms-
expressing cells (Figure 1A,B). We concluded that accumulation of ms in the ER per se confers pro-
teotoxicity when the UPR is dysfunctional, and that the UPR counteracts this proteotoxicity, in partic-
ular through the ATF6a branch.
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IRE1a and PERK are expendable, but ATF6a is key for ER expansion in
response to ms expression
Despite the persistently maximal signaling through the PERK and IRE1a pathways upon ms expres-
sion in ATF6a-silenced cells (Figure 1C,D), upregulation of BiP was compromised (Figure 1C,D;
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Figure 1. ATF6a is essential but IRE1a and PERK are dispensable for restoring ER homeostasis upon ms expression. (A–D) In HeLa-ms cells, IRE1a was
deleted (KO), and ATF6a and PERK were silenced (KD) either alone or in combination, or not (-), as indicated. (A) Cells were seeded upon 1:5 serial
dilution into 24-well plates, and treated with 0.5 nM mifepristone (Mif) to induce expression of ms where indicated (+). After 7 days of growth, cells were
fixed and stained with crystal violet. (B) Staining in (A) was quantitated as a measure for cell growth. Mean and s.e.m. are shown in a bar graph; n = 2.
(C) Expression of ms was induced for 0 or 3 days. Immunoblotting of lysates from cells that were sufficiently viable upon the insult for analysis revealed
levels of ms, BiP, CHOP, a-tubulin, and ATF6a processing (i.e. release of the p50 cleavage product from the p90 precursor); cross-reaction of the
secondary antibody against anti-ATF6a with ms is denoted (ms). RT-PCR fragments corresponding to spliced (XBP
S) and unspliced (XBPU) were separated
on gel. A hybrid product that is formed during the PCR reaction is denoted by an asterisk. (D) BiP levels in (C) were quantitated and expressed as fold
change upon ms expression compared to untreated cells. Mean and s.e.m. are shown in a bar graph; n=2-5. Statistical significance of differences in
growth (B), or in expression levels (D), was tested by ANOVA (*p  0.05; **p  0.01; ***p  0.001).
DOI: https://doi.org/10.7554/eLife.41168.002
The following source data is available for figure 1:
Source data 1.
DOI: https://doi.org/10.7554/eLife.41168.003
Vitale et al. eLife 2019;8:e41168. DOI: https://doi.org/10.7554/eLife.41168 3 of 17
Research advance Cell Biology
B C
D
E
A
Vitale et al. eLife 2019;8:e41168. DOI: https://doi.org/10.7554/eLife.41168 4 of 17
Research advance Cell Biology
Figure 2C,E), while upregulation of two other ER chaperones, PDI, and GRP94 was abolished (Fig-
ure 2—figure supplement 1), which confirms that also these ER chaperones are prominent ATF6a
targets (Bommiasamy et al., 2009). ATF6a silencing did not affect accumulation of ms (Figure 2C,
D), however, and the ER did not expand (Figure 2A, B), in accordance with the compromised upre-
gulation of ER chaperones. Conversely, ER expansion (Figure 2A, B), and BiP upregulation
(Figure 1C, D) upon ms expression was not compromised in PERK– and/or IRE1a–ablated
cells. Thus, the ATF6a branch of the UPR is the main if not sole driver of ER expansion in response
to ms expression.
ER stress and ensuing cytotoxicity levels correlate with the extent of ms
being chaperoned
Since the UPR induces expression of ER resident chaperones, we surmised that ms-driven ER stress
becomes cytotoxic when the UPR is compromised, in particular upon ATF6a ablation, due to ‘under-
chaperoning’ of ms. Proteins that undergo folding tend to aggregate in absence of sufficient folding
assistance. Upon ablation of IRE1a and ATF6a, ms indeed formed extensively disulfide-linked high
molecular weight species that partitioned into a NP40-insoluble fraction, indicative of aggregation
(Mattioli et al., 2006; Valetti et al., 1991)—with the single ablations showing intermediate pheno-
types—(Figure 3A).
Under basal conditions, a significant proportion of BiP readily converts into an inactive, AMPy-
lated state upon a three-hour block of protein synthesis with cycloheximide (CHX) (Figure 3B), which
indicates that BiP gets to be dismissed from its chaperoning duties once its regular clients have had
sufficient time to complete their folding, as has been reported before (Preissler et al., 2015). Con-
versely, in ms-expressing cells no AMPylation occurred upon CHX treatment at any time upon the
onset of ms expression (Figure 3B), suggesting that the vast majority of BiP is permanently engaged
in chaperoning ms even though the BiP pool is expanding massively in response to ms
expression (Bakunts et al., 2017).
As BiP stands out as a key chaperone for orphan ms, we reasoned that the level of BiP at basal
conditions is a key determinant for ms-driven ER stress susceptibility. To test this idea, we created a
derivative of the HeLa-ms cell line with an integrated copy of the hamster HSPA5 gene that encodes
BiP under control of doxycycline (Dox). The induction of ms with Mif leads to it being the most abun-
dantly transcribed gene (Bakunts et al., 2017) in the cells and concomitant induction of other trans-
genes would lead to competition for the transcription and/or translation machineries (not shown),
thereby mitigating ms expression and, hence, ms-driven ER stress by default. We therefore decided to
pre-emptively enhance BiP levels with Dox at least ~10 fold prior to induction of ms expression
(Figure 3C). Even though exogenously driven BiP transcription ceased after that, exogenous (ham-
ster) BiP levels remained high for a prolonged time (Figure 3C).
Figure 2. ATF6a is essential but IRE1a and PERK are dispensable for upregulation of ER chaperones and ER expansion in response to ms expression.
(A,B) HeLa-ms cells in which UPR transducers were ablated by silencing alone or in combination, or not (WT), as indicated, were induced with 0.5 nM Mif
to express ms for 3 days or not. The cells harbor APEX-KDEL, a modified version of pea peroxidase that is targeted to the ER, and that catalyzes
polymerization of 3,3’-diaminobenzidine tetrahydrochloride (DAB) upon treatment with H2O2 to obtain DAB precipitates (dark), revealing the extent of
the ER in electron micrographs. Boxed areas are shown by 3-fold magnification; scale bars represent 1 mm (A). The extent of ER expansion was
assessed as described (Bakunts et al., 2017), and the percentage of the area within the cytoplasm corresponding to ER was determined and depicted
in bar graphs (B). Mean and s.e.m. are shown, n = 10–20. (C–E) Cells were induced to express ms for the indicated times. Levels of ms (D) and BiP (E)
were quantitated from (C), and replicate experiments. (D) Levels in WT of ms at 64 hr were set at 100 that was scaled to levels of BiP in WT at 64 hr such
as to reflect a ratio of ms to BiP of 2:3, that is an estimate for this ratio at day three based on earlier quantitations that we have described
(Bakunts et al., 2017). Mean and s.e.m. are shown in bar graphs; n = 2–5. Statistical significance in the extent of ER areas in the electron micrographs
between ms-expressing or non-expressing cells (black), or between ms-expressing WT or ATF6a ablated cells (red) (B), or in expression levels (D,E) was
tested by ANOVA (n.s., not significant; *p0.05; **p0.01; ***p0.001).
DOI: https://doi.org/10.7554/eLife.41168.004
The following source data and figure supplement are available for figure 2:
Source data 1.
DOI: https://doi.org/10.7554/eLife.41168.005
Figure supplement 1. ATF6a ablation compromises ER chaperone upregulation upon ms expression.
DOI: https://doi.org/10.7554/eLife.41168.006
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In line with the notion that ER stress sensing in the HeLa-ms model occurs in a ms/BiP ratiometric
fashion (Bakunts et al., 2017), and in line with earlier reports that BiP overexpression dampens UPR
activation (Bertolotti et al., 2000), XBP1 mRNA splicing and upregulation of the UPR target GRP94
occurred with a delay when BiP levels were exogenously boosted as compared to when BiP was at
endogenous levels, in spite of the similar extent and kinetics of ms accumulation (Figure 3C). Alto-
gether the HeLa-ms model thus provides further support that sensing of ER stress correlates with the
extent of the folding machinery being engaged in chaperoning its clients, and that BiP sequestration
by client proteins appears to serve as the main proxy for that.
Turnover of ms as afforded by ERAD is remarkably robust
While ms levels increase, and the ER expands (~3–4 fold compared to basal levels), as wild-type cells
are still adapting to the proteostatic insult, there is no further build-up of ms levels and ER expansion
after ~2–3 days once homeostasis is restored (Bakunts et al., 2017), which implies that at that stage
the influx of ms molecules into the ER must be matched by countermeasures. Translational attenua-
tion through PERK activation can alleviate the burden on the ER folding machinery by diminishing
the input of nascent clients entering the ER lumen (Harding et al., 1999). Yet, we ruled out that
PERK-driven translational attenuation was a key determinant for ER homeostatic readjustment in the
HeLa-ms model, considering that PERK ablation hardly impeded cell growth upon ms expression
(Figure 1A,B). Accordingly, there was only a marginal reduction in overall protein synthesis (being at
the lowest ~80% of that before induction) that was moreover transient (i.e. only manifest during the
first 16 hr of ms-expression) (Figure 4—figure supplement 1). Following the same reasoning, we
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Immunoblotting of lysates revealed levels of ms, total BiP, hamster BiP, and GRP94. XBP1 mRNA splicing was assessed as in Figure 1C.
DOI: https://doi.org/10.7554/eLife.41168.007
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also ruled out that regulated IRE1a-dependent decay (RIDD) (Hollien and Weissman, 2006;
Hollien et al., 2009) of mRNAs that encode ER client proteins (and thereby limiting their influx into
the ER) is important for homeostatic readjustment upon ms expression, since ablation of IRE1a had
negligible impact on cell growth (Figure 1A,B). However, ms is a target of ERAD, as has been shown
in plasma cells (Fagioli and Sitia, 2001), and which is shown here for the HeLa-ms cell model, since
the proteasomal inhibitor MG132 to a large extent stabilizes ms levels in pulse-chase assays
(Figure 4A,B). Since ms is glycosylated, it is subject to mannose trimming (Aebi et al., 2010), which
is a key step in delivering ms to the retro-translocation machinery that shuttles it to the cytosol for
proteasomal degradation (Fagioli and Sitia, 2001). Accordingly, the ER mannosidase I inhibitor kifu-
nensine (Kif) stabilized ms in a similar manner as MG132 (Figure 4A,B).
Interestingly, while ms levels built up steadily in the ER with time, ERAD kinetics hardly changed
(i.e. the half-life (t½) of ms was remarkably constant), which implies that ERAD prowess kept pace
with the accumulating load of ms (Figure 4C). ERAD components are UPR target genes (Walter and
Ron, 2011), and indeed various major ERAD components (HRD1, SEL1L, Ube2j1, HERP, and OS-9),
which we previously failed to detect by proteomics (Bakunts et al., 2017), were upregulated upon
ms expression (Figure 4—figure supplement 2), Yet, their upregulation apparently serves at most to
maintain rather than to reinvigorate ERAD kinetics of the accumulating ms load. In fact, ERAD kinetics
of ms were not markedly affected by ablation of ATF6a (Figure 4D,E), in line with the finding that
intracellular ms accumulation was not aggravated upon ATF6a ablation (Figure 2C,D). Thus, ER
homeostatic failure upon ATF6a ablation is not due to compromised ERAD. Apparently, the upkeep
of ERAD is robust in HeLa-ms cells, since we can also rule out that IRE1a and/or PERK are essential
for maintaining sufficient ERAD capacity, as their ablation hardly caused any growth impairment of
ms-expressing cells (Figure 1A,B), unlike when ERAD is inhibited—see below.
A
B
0 3 6   
8
16
128
32
64
chase (hrs)
tim
e 
si
nc
e 
on
se
t
o
f 
 
e
xp
re
ss
io
n 
(hr
s)
t1/2 (hrs)
6.3
7.0
5.3
5.7
6.4
Kif
MG132
0 3 6
chase (hrs)
6 6   
+
+
0
50
100
 
le
ve
ls
 (A
U)
 
-
0 6   
chase (hrs)
E
0
50
100
 
le
ve
ls
 (A
U)
 
ATF6_ KD
C D
µ
S
µ
S
µ
S
µS-µS
Figure 4. ERAD accounts for disposal of ms in a robust manner. HeLa-ms cells, in which ATF6a was ablated (D,E), as indicated, or not (A-C) were pulse
labeled for 10 min and chased with excess unlabeled cysteine and methionine for the indicated times after 24 hr (A,B,D,E) or at various times (C), as
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of (C) were used to calculate the t½ of ms at various time points after induction of its expression; see column on the right of panel.
DOI: https://doi.org/10.7554/eLife.41168.008
The following source data and figure supplements are available for figure 4:
Source data 1.
DOI: https://doi.org/10.7554/eLife.41168.012
Figure supplement 1. Translation is transiently attenuated upon ms overexpression to a marginal extent.
DOI: https://doi.org/10.7554/eLife.41168.009
Figure supplement 1—source data 1.
DOI: https://doi.org/10.7554/eLife.41168.010
Figure supplement 2. Levels of various ERAD components are induced in response to ms expression.
DOI: https://doi.org/10.7554/eLife.41168.011
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Disposal of ms through HRD1 complex-mediated ERAD is key for
homeostatic readjustment
While prolonged proteasomal inhibition in itself is cytotoxic, blocking ERAD of glycoproteins with Kif
per se did not affect cell viability (Figure 5A), and did not activate the UPR either (Figure 5—figure
supplement 1). We reasoned that ERAD would be important, however, to hold bulk accumulation of
ms in check. Indeed, viability was compromised in Kif-treated ms-expressing cells (Figure 5A). Key
ERAD components are the E3 ligase HRD1 and its partner SEL1L (Olzmann et al., 2013), which have
previously been shown to mediate ERAD of ms (Cattaneo et al., 2008). Indeed, ablation of HRD1
and, to a lesser extent, of SEL1L was synthetically lethal in HeLa-ms cells upon ms expression
(Figure 5A).
HRD1 and SEL1L cooperate to target ERAD substrates back across the ER membrane to the cyto-
sol, where substrates are ubiquitinated, deglycosylated by N-glycanase, and, ultimately, degraded
by the proteasome (Olzmann et al., 2013). Accordingly, ms was stabilized in HRD1 KO or SEL1L KD
cells, similarly as upon Kif treatment of WT cells, while in ERAD-competent WT cells ms was degraded
upon CHX treatment (Figure 5B,C). Proteasomal inhibition with MG132 stabilized ms in WT cells,
and the appearance of a deglycosylated form of ms confirmed that, at least of fraction of ms was ret-
rotranslocated to the cytosol, and accessible to N-glycanase. Interestingly, in HRD1 KO or SEL1L KD
cells no deglycosylated form of ms appeared, indicating that disposal of ms was blocked at (or prior
to) the retrotranslocation step (Figure 5C).
There appear to be more than 25 other E3 ligases that localize at the ER membrane next to
HRD1 (Neutzner et al., 2011; Kaneko et al., 2016), but, curiously, none of these can compensate
for the loss of HRD1. Furthermore, treatment with the autophagy inhibitor Bafilomycin A1 (BafA1)
did not lead to any stabilization of ms (Figure 5B). Thus, HRD1-mediated ERAD is the main if not
exclusive disposal mechanism that is essential for ER homeostatic readjustment in the HeLa-ms
model, even though autophagy has been reported to curtail IgM production and ER expansion in
plasma cells (Pengo et al., 2013).
The synthetic lethality that ensues once ERAD is compromised in the HeLa-ms model offered a
powerful tool to define which factors are crucial to act in conjunction with HRD1 and SEL1L in the
disposal of ms. To that end, we ablated several candidate HRD1 partners by CRISPR/Cas9 (but with-
out clonal selection; that is without necessarily reaching fully penetrant phenotypes). In this initial
survey, we witnessed that cell viability upon ms-expression was compromised, and that ms was stabi-
lized in a CHX chase by ablation of HERP, Ube2j1, and Derlin2 to significant extents (Figure 5—fig-
ure supplement 2). However, ablation of OS-9 or of XTP3-B only mildly affected ms-expressing cells.
These two lectins indeed have been shown previously to be interchangeable, as they capture soluble
ERAD substrates upon mannose trimming of their glycans before handing over these substrates to
SEL1L (Bernasconi et al., 2010; van der Goot et al., 2018).
In sedimentation gradients HRD1, SEL1L, and Derlin2 shifted towards heavier fractions upon ms
expression, while the redundant ERAD factor OS-9 did not (Figure 5D). These findings indicate that
disposal of ms is effectuated through assembly of higher-order ERAD-mediating complexes with, at
the least, HRD1, SEL1L, and Derlin2 at their core. These complexes nucleate around HRD1 as its
ablation abrogated their formation (Figure 5D).
Homeostatic failure upon ERAD inhibition coincides with ms levels
outpacing BiP upregulation
When ERAD is functional, an excess of BiP over ms is restored upon 3 days of ms expression. The
BiP:ms stoichiometry is then ~3:2, as estimated from a combination of quantitative immunoblotting
and proteomics techniques (Bakunts et al., 2017). As soon as BiP levels are in excess again, UPR
signaling subsides to submaximal output, and ER homeostatic readjustment to ms expression is suc-
cessful (Bakunts et al., 2017). The loss of viability in Kif-treated ms-expressing cells (Figure 5A) indi-
cated that ER homeostatic readjustment failed, and these cells indeed underwent apoptosis
(Figure 6A). Homeostatic failure in Kif-treated ms-expressing cells entailed that ER stress was unre-
solved, and accordingly, IRE1a and PERK chronically signaled at maximal levels (Figure 6B).
Chronic maximal UPR activation upon ERAD inhibition in ms-expressing cells implied that induc-
tion of BiP expression was persistently at maximal levels. Nevertheless, the build-up of BiP levels (~2
fold further increase after 3 days), could not keep pace with the augmented accumulation of ms (~3
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Figure 5. ERAD of ms is mediated through the HRD1 complex. (A) Growth assay as in Figure 1A of HeLa-ms cells, in which HRD1 was deleted (KO),
SEL1L was silenced (KD), or not (WT). Cells were treated with 0.5 nM mifepristone (Mif) to induce expression of ms (+), or not (-), and WT cells were
treated with Kif or not (ctrl), as indicated. (B,C) Immunoblots of ms harvested from WT, HRD1 KO (B,C), or SEL1L KD (C) HeLa-ms cells that were induced
with 0.5 nM Mif to express ms for 4 hr and then treated for the indicated times with 100 mg/ml CHX either alone (B,C), in combination with 20 mM Kif,
100 nM BafA1, or not (ctrl) (B), or 10 mg/ml MG132 (C), as indicated. The arrowhead indicates the deglycosylated form of ms. (D) HeLa-ms WT or HRD1
KO cells were induced with Mif (0.5 nM) for 24 hr to express ms or not (ctrl) , as indicated. Samples were lysed in 1% lauryl maltose neopentyl glycol
(LMNG) and sedimented over a 10–40% sucrose gradient. Levels of ms, HRD1, SEL1L, Derlin-2, and OS-9 were detected by immunoblotting. Note that
in HRD1 KO cells leaky expression of ms becomes apparent due to the lack of ERAD. At low expression levels, however, ms does not form high
molecular weight aggregates, indicative of the adequacy of the chaperoning machinery.
DOI: https://doi.org/10.7554/eLife.41168.013
The following figure supplements are available for figure 5:
Figure supplement 1. Inhibition of ERAD does not trigger the UPR under basal conditions.
DOI: https://doi.org/10.7554/eLife.41168.014
Figure supplement 2 . HERP, Ube2j1, and Derlin-2 are key for ERAD of ms.
DOI: https://doi.org/10.7554/eLife.41168.015
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Figure 6. Abrogation of ms disposal through ERAD leads to BiP being permanently eclipsed, ER homeostatic failure, and apoptosis. (A,D,E) HeLa-ms
cells, harboring APEX-KDEL (D,E) or not (A) were induced with (ms) or without (ctrl) 0.5 nM Mif for 3 days in the presence or absence of 30 mM Kif. (A)
Percentages of Annexin V positive cells were assessed by cytometric analysis. Mean and s.e.m. are shown in a bar graph, n = 2–4. (B,C) HeLa-ms cells
were induced to express ms for various times as indicated (B) or for 3 days in the absence or presence of 30 mM Kif. (C) Levels of ms, BiP, and a-tubulin
as well as activation of the IRE1a and PERK branches of the UPR were assessed as in (Bakunts et al., 2017). (B) Levels of BiP and ms were assessed by
quantitative immunoblotting as described (Bakunts et al., 2017), and depicted in bar graphs as in Figure 2D,E, such that the ms levels in the absence
of Kif were scaled to BiP levels at a ratio of 2:3. Levels in the presence of Kif are expressed as a fold change compared to levels in the absence of Kif;
mean and s.e.m. are shown; n = 2. (D) In cells harboring APEX-KDEL the extent of ER expansion was assessed as in Figure 2A. Boxed areas are shown
by 3-fold magnification; scale bars represent 1 mm. The percentage of the dark area within the cytoplasm corresponding to ER was determined and
depicted in bar graphs (E), mean and s.e.m. are shown, n = 10. Statistical significance of differences in Annexin V staining (A), or the extent of ER
occupying cytosolic area in the electron micrographs (E) were tested by ANOVA (*p0.05; ***p0.001).
DOI: https://doi.org/10.7554/eLife.41168.016
The following source data is available for figure 6:
Source data 1.
DOI: https://doi.org/10.7554/eLife.41168.017
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fold further increase after 3 days) upon ERAD inhibition, such that ms reached levels in the ER that
were at about a 1:1 stoichiometry with BiP (Figure 6C). Indeed, aggregation of ms increased when
ERAD was defective, as judged by ms shifting more towards heavier fractions in HRD1 KO than in WT
cells (Figure 5D). Thus, under those conditions the chaperoning machinery becomes limiting, simi-
larly as upon ablation of IRE1a and/or ATF6a in ERAD-competent cells (Figure 3A).
We previously estimated the volume of the ER under basal conditions to be (0.10–0.12)3/2 » 3–4%
of the cytoplasmic volume, and upon 3 days of ms expression to be (0.18–0.20)
3/2 »7–8% of the cyto-
plasmic volume, corresponding to a ~ 2–3 fold increase of ER volume (Bakunts et al., 2017). Upon
ERAD inhibition with Kif the ER did not markedly expand in non-ms-expressing cells. In ms-expressing
cells, instead, ERAD inhibition caused the area of ER staining within the cytoplasm to reach 30–35%,
which on a rough estimate would account for (0.3–0.35)3/2 » 17–20% of the cytoplasmic volume,
implying that the ER had expanded ~6–7 fold since the onset of ms-expression (Figure 6D,E).
We concluded that curtailing the ms load by ERAD is essential for the cells to cope with ms expres-
sion in bulk. ER homeostatic failure upon ERAD inhibition coincided with an inadequacy to raise BiP
levels in sufficient excess over those of ms and, hence, with its ‘under-chaperoning’, in spite of the
impressive BiP upregulation and ER expansion at large. Thus, in absence of ERAD, not only the
chronic maximal UPR activation, but also the ms–driven proteotoxicity appear to be due to BiP run-
ning short, similarly as when UPR signaling was compromised upon ablation of ATF6a (Figure 1C,D;
Figure 2C–E).
Sequestration of BiP is both necessary and sufficient for UPR activation
and ER stress-provoked proteotoxicity
In plasma cells BiP stringently interacts with ms through the CH1 domain, until it is displaced by the
light chain (Bole et al., 1986; Figure 7A), which makes ms an unusual ER client. Evolutionary pressure
against secretion of orphan ms (i.e. unaccompanied by the light chain) must have been extraordinarily
high for obvious immunological reasons (Anelli and van Anken, 2013), which would explain the
exceptionally strong affinity of the CH1 domain for BiP, that is to let BiP mediate stringent ER reten-
tion of unpaired ms. Thus, we reasoned that removal of the BiP binding CH1 domain from ms
(Figure 7A), would offer an ideal tool to validate whether limitations in BiP availability define both
the amplitude of UPR activation as well as any proteotoxicity that would ensue from overexpression
of ER client proteins. In line with our model, msDCH1 hardly activated the UPR, as shown for the
IRE1a and PERK branches, despite being expressed at similar levels as ms wild-type (Figure 7B).
Moreover, genetic ablation of the three UPR pathways failed to cause synthetic lethality in msDCH1-
expressing cells (Figure 7C). Conversely, co-expression of msDCH1 with a chimeric protein consisting
of the variable domain of l fused with the CH1 domain of ms (VL-CH1), which teams up with msDCH1
through interactions between VL with the variable domain of ms (VH) (Figure 7A), restored UPR acti-
vation (Figure 7B) and synthetic lethality upon UPR ablation (Figure 7C). These findings corroborate
that the BiP sequestering CH1 domain of ms causes UPR activation, as well as proteotoxicity when
reinforcement of BiP levels through the UPR is inadequate.
Discussion
The fact that BiP plays a key role in regulating the UPR has been known for almost 20 years
(Bertolotti et al., 2000). Overexpression of BiP dampens UPR activation (Bertolotti et al., 2000),
which we confirm with the data presented here, while inactivating BiP with the AB5 subtilase cyto-
toxin acutely causes ER stress and UPR activation (Paton et al., 2006). Yet, by employment of a pro-
teostatic stimulus with a single well-defined BiP binding module as the source of ER stress, we have
provided here experimental evidence that defines both proteostatic ER stress, and the resulting acti-
vation of the UPR, to be the specific consequence of insufficient BiP availability. Both the UPR and
ERAD redress the relative BiP shortage, and thus counteract that the proteostatic stress becomes
proteotoxic. BiP indeed has been acclaimed as the master regulator of ER function (Hender-
shot, 2004), and various cytotoxic consequences may follow from the excessive sequestering of BiP
by ms that precludes BiP from attending to its other functions. For instance, BiP closes off the translo-
con, and efflux of Ca2+ from the ER into the cytosol through poorly gated translocons may already
be sufficient to cause apoptosis (Scha¨uble et al., 2012).
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Our data emphasize that proteotoxicity stemming from the accumulation of client proteins in the
ER is not the result of UPR signaling, as often is assumed from the notion that the UPR can initiate
pro-apoptotic pathways. Instead, the UPR foremost counteracts proteotoxicity by inducing the ER
resident folding machinery (most in particular BiP). In light of our data, the capacity of the UPR to
switch from cytoprotective to pro-apoptotic signaling may well have arisen in metazoans to pre-
emptively eliminate cells in which restoration of ER homeostasis is unachievable, and, hence, cell
death has become inevitable.
Perhaps surprisingly, our results furthermore highlight that PERK and IRE1a are dispensable for
successful ER homeostatic readjustment to the ms stimulus in HeLa cells. Apparently, the PERK-medi-
ated translational block, which is only transient, offers negligible advantage when cells face a sudden
proteostatic insult that sequesters BiP (and/or the ER chaperone machinery at large) in a persistent
manner. PERK-mediated translational attenuation instead may be required in particular to sustain
episodic secretory activity, such as in b-cells of the pancreas. PERK KO mice indeed suffer mostly
from degeneration of tissues with episodic secretory activity (Zhang et al., 2002). Similarly, require-
ments for the IRE1a/XBP1 pathway seem to be tissue-specific. Both deletion of IRE1a (Urano et al.,
2000; Zhang et al., 2005) and of XBP1 (Reimold et al., 2000) cause embryonic lethality, but XBP1
KO mice are rescued with an XBP1 transgene specifically expressed in the liver (Lee et al., 2005),
while IRE1a KO mice are rescued when the placenta expresses IRE1a (Iwawaki et al., 2009), and
the resulting rescued mice display relatively mild symptoms, that ishyperglycemia, hypoinsulinemia,
and decreased antibody titers, despite the lack of IRE1a (Iwawaki et al., 2010). In line with our
Figure 7. The BiP-sequestering CH1 domain of ms is necessary and sufficient to cause UPR activation and proteotoxic ER stress in absence of the UPR.
(A) Schematic representation of BiP associating with the CH1 domain of ms until it is displaced by the light chain (l). Deletion of the CH1 domain (mD)
abolishes BiP association, but through pairing of the VH and VL domains, the CH1 domain can associate in trans by virtue of a synthetic chimeric VL-CH1
construct. (B) HeLa cells were induced for 24 hr with 0.5 nM Mif to express the transgenes ms, msDCH1 (mD) alone or in conjunction with VL-CH1, as
indicated. Immunoblotting of lysates revealed levels of ms, mD, VL-CH1, BiP, CHOP, and a-tubulin, as in Figure 1A. (C) Growth assay as in Figure 1A of
HeLa cells inducibly expressing ms, msDCH1 (mD) in conjunction with VL-CH1 or not, and in which the UPR was ablated (i.e. IRE1a was deleted (KO), and
ATF6a and PERK were silenced in combination), or not, as indicated.
DOI: https://doi.org/10.7554/eLife.41168.018
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findings, homeostatic readjustment to ER stress in most mammalian tissues seems to rely mainly on
ATF6 proteins (Wu et al., 2007; Yamamoto et al., 2007), that is ATF6a, and its related ER stress
sensor ATF6b. The ATF6a/b double KO confers embryonic lethality (Yamamoto et al., 2007). At
present, it is unclear whether embryonic lethality of the ATF6a/b double KO can be rescued, for
instance through enhancement of other UPR branches.
Finally, since proteotoxicity due to the accumulation of (mutant) proteins in the ER seems to play
a key role in various types of disease (Anelli and Sitia, 2010; Cao and Kaufman, 2014), our insights
may be of relevance for the design of drugs aimed at alleviating ER stress (Hetz and Papa, 2018),
and hence proteotoxicity stemming from ER stress. We argue that pharmacological intervention
against pathogenic ER stress foremost should promote a favorable ratio of BiP levels over those of
its disease-causing client protein.
Materials and methods
All assays were performed as described (Bakunts et al., 2017), except that in addition, along the
same principles as described (Bakunts et al., 2017), the following cell lines were derived by clonal
selection from either HeLa-ms or HeLa-MifON, as summarized in Supplementary file 1: HeLa-ms
HRD1 KO, and HeLa-ms-BiP
H, which inducibly (by Dox) expresses hamster BiP, HeLa-msDCH1, which
inducibly (by Mif) expresses msDCH1, and HeLa-msDCH1/VL-CH1, which inducibly (by Mif) expresses
msDCH1 in combination with VL-CH1. At least three independent clones of HeLa-ms HRD1 KO cells
were tested in phenotypic assays to rule out off-target effects. CRISPR/Cas9-mediated depletion of
HERP, Ube2j1, Derlin-2, OS-9, or XTP3-B in HeLa-ms was performed using single guide RNA (sgRNA)
sequences (Supplementary file 1) cloned into the PX459 vector (Addgene #62988) and were used
as puromycin-selected pools without clonal isolation. Cloning into PX459 was performed as
described previously (Ran et al., 2013). sgRNA target sequences for Hrd1, HERP (Schulz et al.,
2017), Derlin-2, Ube2j1 (Ma et al., 2015), OS-9, and XTP3-B (van der Goot et al., 2018) have been
described previously. Silencing of SEL1L was obtained using ON-Target SMARTpool siRNA from
Dharmacon.
The inducible hamster BiP, msDCH1 and VL-CH1 cassettes were created by standard molecular
biology techniques from the cDNAs described in Bakunts et al. (2017). The CH1 domain (E140-
P244) was deleted from ms in msDCH1. That same CH1 domain was placed downstream of V127 of l,
replacing the CL domain, to create the chimeric VL-CH1 construct. A myc tag (EQKLISEEDL) was
placed at the C-terminus of VL-CH1 for immunodetection purposes. Cells were routinely tested,
that is on a monthly basis, to be mycoplasm-free by use of a standard diagnostic PCR. All cell lines
in this study were ultimately derived from HeLa S3 cells, of which the genotype was confirmed by
PCR single locus technology. Antibodies used in addition to those described before (Bakunts et al.,
2017) are summarized in Supplementary file 1.
To separate NP-40 soluble from insoluble fractions, cells were washed and lysed in 0.2% NP-40,
50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 10 mM N-ethylmaleimide and a cocktail of pro-
tease inhibitors. The NP-40-insoluble fractions were separated from the soluble fractions by centrifu-
gation at 3,400 g for 10 min and the insoluble pellets were solubilized in 1% SDS, 50 mM Tris-HCl
pH 7.5, 10 mM NEM for 10 min at RT and sonicated on ice. For fractionation of ERAD complexes
cells were lysed in 1% lauryl maltose neopentyl glycol (LMNG, Anatrace) containing buffer (50 mM
Tris-HCl, pH7.4, 150 mM NaCl, 5 mM EDTA) and lysates were loaded onto 10–40% sucrose gra-
dients also containing 1% LMNG, formed by following the manufacturers’ instructions (Gradient
Master, Biocomp). Sedimentation was achieved by centrifugation in a SW.41 swing bucket rotor
(Beckman) at 39,000 rpm for 16 hr at 4˚C. Thirteen fractions were collected from the top and pro-
teins precipitated with TCA (trichloroacetic acid). Protein pellets were resuspended in Laemmli
buffer containing DTT (10 mM), heated alongside 25 mg of the original lysates as input, at 56˚C prior
to separation by SDS-PAGE.
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